 Aged, 80 and over
"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 33 | 33 | | 1996 | 0 | 30 | 30 | | 1997 | 0 | 37 | 37 | | 1998 | 0 | 45 | 45 | | 1999 | 0 | 47 | 47 | | 2000 | 0 | 57 | 57 | | 2001 | 0 | 73 | 73 | | 2002 | 0 | 64 | 64 | | 2003 | 1 | 88 | 89 | | 2004 | 0 | 83 | 83 | | 2005 | 0 | 131 | 131 | | 2006 | 0 | 153 | 153 | | 2007 | 1 | 169 | 170 | | 2008 | 0 | 167 | 167 | | 2009 | 0 | 185 | 185 | | 2010 | 1 | 219 | 220 | | 2011 | 0 | 236 | 236 | | 2012 | 0 | 232 | 232 | | 2013 | 1 | 256 | 257 | | 2014 | 0 | 257 | 257 | | 2015 | 2 | 309 | 311 | | 2016 | 0 | 329 | 329 | | 2017 | 0 | 322 | 322 | | 2018 | 0 | 344 | 344 | | 2019 | 0 | 364 | 364 | | 2020 | 0 | 287 | 287 | | 2021 | 0 | 221 | 221 | | 2022 | 0 | 47 | 47 | | 2023 | 0 | 46 | 46 | | 2024 | 0 | 235 | 235 | | 2025 | 0 | 77 | 77 |
To return to the timeline, click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Jazowski SA, Achola EM, Nicholas LH, Kwon Y, Wood WA, Friese CR, Dusetzina SB. Medicare Plan Switching Among Beneficiaries With and Without a History of Cancer. JAMA Netw Open. 2025 Jun 02; 8(6):e2513394.
-
Benz MB, Rudolph JL, DeVone F, Bayer TA, Garbin A, Singh M, Gravenstein S, Hartronft S, Toms R, Gaudiano BA, Metrik J, Browne J. Depressive Symptoms Before and During the COVID-19 Pandemic in Veteran Nursing Home Residents. Int J Geriatr Psychiatry. 2025 06; 40(6):e70108.
-
Sabri SA, Laynes RA, Hoffman CJ, Chavarria JC, Prusick PJ, Weesner RE, Stringer N, Farrell JP, Gimarc D, Lowry MK, Patel V, Ou-Yang D, Burger-Van Der Walt E, Kleck CJ. Implications of lumbosacral transitional anatomy on vertebral numbering: evaluation of 3147 adult full-length spine radiographs. Neurosurg Focus. 2025 Jun 01; 58(6):E13.
-
Guo AA, Knapp MP, Evans JK, Faucheux AT, Price SN, Klepin HD, Levine B, Quattlebaum A, Bloomer C, Khoury L, Hunting JC, Elko CA, Olson E, Lycan TW. Impact of comorbidity on immune-related adverse events and survival in older cancer patients treated with immunotherapy. Future Oncol. 2025 Jun; 21(14):1787-1796.
-
Rodr?guez-Lobato LG, de Daniel A, Pereira A, Fern?ndez de Larrea C, Tovar N, Cibeira MT, Moreno DF, Mateos JM, Llobet N, Carcelero E, Mun?rriz D, Blad? J, Rosi?ol L. Attrition rates and treatment outcomes in multiple myeloma: real-world data over a 40-year period. Blood Cancer J. 2025 May 26; 15(1):103.
-
Craig A, Shihadeh KC, Knepper BC, Miller W, Young HL, Aragon D, Jenkins TC. Antibiotic adherence and treatment completion associated with partial oral therapy versus all intravenous therapy in patients with serious Staphylococcus aureus infections. BMC Infect Dis. 2025 May 17; 25(1):714.
-
Hyams C, Challen R, Lahuerta M, Begier E, McGuinness S, Clout M, Southern J, Campling J, Oliver J, Theilacker C, Ellsbury G, Maskell N, Gessner BD, Danon L, Finn A. Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023. BMJ Open Respir Res. 2025 May 16; 12(1).
-
Gouda MA, Voss MH, Tawbi H, Gordon M, Tykodi SS, Lam ET, Vaishampayan U, Tannir NM, Chaves J, Nikolinakos P, Fan A, Lee R, McDermott D, Shapiro GI, Gandhi L, Bhatia S, Katragadda V, Meric-Bernstam F. A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer. ESMO Open. 2025 May; 10(5):104536.
-
Girard N, Xu Q, Camidge DR, Baijal S, Ng S, Kamalakar R, Ratajczak C, Alhasani H, Crawford S, Karve S, Lu S. Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101. Oncologist. 2025 May 08; 30(5).
-
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nat Commun. 2025 May 07; 16(1):4235.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|